Allergan Aesthetics, an AbbVie company (NYSE:ABBV), announced on Wednesday that Natrelle has been named as a supplier by Vizient Inc, a healthcare performance improvement company.
This agreement connects Natrelle to Vizient's extensive network of academic medical centres, community hospitals, integrated delivery networks, and non-acute care providers, representing more than half of US healthcare organisations.
Under the contract, Vizient clients will gain enhanced access to Natrelle's offerings, including more than 300 implant options within the most comprehensive breast implant line. Allergan said that providers will also receive competitive pricing, a simplified procurement process, greater operational efficiency, and direct support from the brand's sales and technical teams.
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
WuXi Biologics honoured for water security by CDP
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services